Proceeds will enable the company to meet growing demand for its automated microbial detection platform, currently used by a majority of the top 20 global biopharmaceutical companies, and support new product development for pandemic response. Global investor syndicate is led by Ally Bridge Group, joined by Endeavour Vision, and [...]
DARPin® antiviral candidates demonstrate low picomolar potency in live virus assay Candidate construction complete; two candidates ready for preclinical development & manufacturing Therapeutic profile of a highly potent antiviral biologic with a long half-life supports both a prophylactic and therapeutic approach Initiation of clinical studies planned for H2 2020 [...]
Endeavour Vision’s Co-Founder and Managing Partner, Bernard Vogel, spoke to the Swiss news publication, AGEFI, to share his insights on the impact of COVID-19 on Swiss start-ups, the medtech sector and the firm’s investment strategy. Scroll down for the English translation. Published in AGEFI on 20 April, 2020. Pour [...]
In June 2019, Bradley Paddock joined CeQur®, as Chief Executive Officer. We spoke to Bradley to hear about his first 6 months in the company and discuss the up-coming U.S. launch of its three-day insulin delivery device for type 2 diabetes. You probably had many career options after Kyphon [...]
Interview with Dennis Wahr, President and CEO, Nuvaira In 2019, Nuvaira was accepted into a unique program developed by the Haute Autorité de Santé (HAS, the French health technology assessment agency), the Forfait Innovation Program. We spoke to Nuvaira’s CEO Dennis Wahr to learn more. Can you summarise [...]
Endeavour Vision Founding Partners Damien Tappy and Bernard Vogel spoke to AGEFI about the next fund and the firm’s investment approach. Read the article from AGEFI here Medtech: Endeavour Vision accélère ses investissements en Suisse et aux USA Basée à Genève, Endeavour Vision va lancer son second fonds medtech [...]
Previously Vice President, Corporate Business Development at Boston Scientific. Rob, you joined Endeavour Vision after 15 years working at Boston Scientific, can you summarise your role there? My job was to assess and execute business development transactions including acquisitions, joint ventures, distribution deals and minority investments etc. on behalf [...]
Can you tell us a bit about Relievant Medsystems and the Intracept® Procedure? Relievant is a venture-backed medical device company founded in 2006, based in Minneapolis and Sunnydale, California with around 45 employees. Our focus is currently shifting from research and development and clinical trial execution to commercial with [...]
Medical Device Veteran Has 23-Year Record of Successful Commercial and Organizational Leadership MARLBOROUGH, Mass., June 5, 2019 — CeQur® announced that the company has appointed Bradley Paddock as chief executive officer, effective today. Paddock brings a track record of commercial medtech successes, notably leading sales up to $600 million [...]
What is Gynesonics about? How are you changing the standard of care in uterine fibroids? Gynesonics is focused on advancing women’s health by developing uterus-preserving, incision free, transcervical technology. Currently, we are focused on the treatment of symptomatic uterine fibroids, a condition that affects up to 50% of women [...]